Valley National Advisers’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-48
Closed -$1K 957
2025
Q3
$1K Hold
48
﹤0.01% 840
2025
Q2
$1K Hold
48
﹤0.01% 809
2025
Q1
$1K Hold
48
﹤0.01% 813
2024
Q4
$1K Hold
48
﹤0.01% 769
2024
Q3
$1K Hold
48
﹤0.01% 732
2024
Q2
$1K Hold
48
﹤0.01% 1158
2024
Q1
$1K Hold
48
﹤0.01% 1203
2023
Q4
$1K Sell
48
-137
-74% -$3.68K ﹤0.01% 1177
2023
Q3
$5K Hold
185
﹤0.01% 717
2023
Q2
$7K Hold
185
﹤0.01% 664
2023
Q1
$7K Hold
185
﹤0.01% 656
2022
Q4
$6K Hold
185
﹤0.01% 661
2022
Q3
$6K Hold
185
﹤0.01% 667
2022
Q2
$7K Hold
185
﹤0.01% 632
2022
Q1
$8K Hold
185
﹤0.01% 638
2021
Q4
$9K Hold
185
﹤0.01% 626
2021
Q3
$10K Hold
185
﹤0.01% 585
2021
Q2
$11K Hold
185
﹤0.01% 572
2021
Q1
$11K Hold
185
﹤0.01% 531
2020
Q4
$11K Buy
185
+48
+35% +$2.58K ﹤0.01% 516
2020
Q3
$7K Buy
+137
New +$6.61K ﹤0.01% 527

Other funds holding HEAL

Valley National Advisers's HEAL Position: Q4 2025 in Review

Valley National Advisers sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q4 2025, closing a stake of 48 shares — an estimated $1K sold.

Valley National Advisers first reported a position in HEAL in Q3 2020 and held it in 21 quarters. The position peaked at $11K in Q2 2021. 28 funds tracked by Wall St. Rank hold HEAL as of Q4 2025.

  • Valley National Advisers reported no remaining Global X Funds Global X HealthTech ETF position as of Q4 2025 after selling out during the quarter.
  • Valley National Advisers sold 48 Global X Funds Global X HealthTech ETF shares in Q4 2025, an estimated $1K.
  • Valley National Advisers first reported a position in Global X Funds Global X HealthTech ETF in Q3 2020 and held it in 21 quarters.
  • Valley National Advisers's Global X Funds Global X HealthTech ETF position peaked at $11K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q4 2025.

Based on Valley National Advisers's 13F filing for Q4 2025, filed 23 Jan 2026.